Company Number: 14818130

Analysis Date: 2025-07-20 13:29 UTC

Financial Health Assessment Report for ALETHIC LTD

---

1. Financial Health Score: D

Explanation:
ALETHIC LTD is a newly incorporated micro-entity (less than 1 year of trading) showing significant signs of financial distress, reflected in its negative net assets and net current liabilities. The financial "vital signs" indicate serious liquidity challenges, akin to a patient showing symptoms of severe dehydration—urgent intervention is needed to restore stability. While early-stage companies often experience initial losses, the current position requires close monitoring and corrective action.

---

2. Key Vital Signs

Metric	Value	Interpretation
Current Assets	£723	Extremely low cash and receivables; poor liquidity "oxygen" supply.
Current Liabilities	£21,000	Short-term debts significantly outweigh assets, indicating inability to cover immediate obligations—akin to high blood pressure stressing the system.
Net Current Assets	-£20,277	Negative working capital; company owes more than it owns in the short term, a symptom of cash flow distress.
Net Assets (Shareholders’ Funds)	-£20,277	Negative equity; liabilities exceed assets, similar to a patient with a critical deficit in vital reserves.
Number of Employees	2	Small team, typical for a micro entity, but limited resources to manage financial challenges.
Industry	Business and domestic software development (SIC 62012)	Sector typically requires upfront investment in development with delayed revenue recognition, explaining early losses but increasing need for cash management.

---

3. Diagnosis

ALETHIC LTD is in the very early stages of operating life and currently exhibits clear symptoms of financial strain:

• Liquidity Crisis: With current liabilities nearly 30 times higher than current assets, the company is unable to meet its short-term obligations without additional funding or cash inflows. This is the primary symptom of distress.

• Negative Net Worth: The shareholders’ funds are negative, indicating the company has accumulated losses or owes more than it owns. This is not unusual for a startup, but it signals the need for capital infusion or improved profitability soon.

• Early Stage Risk: As a micro-entity operating in software development, initial losses and negative working capital are somewhat expected due to upfront development costs and delayed revenues. However, the magnitude of net current liabilities relative to assets is concerning.

• Governance and Control: The company has two directors and three significant controllers including a corporate entity, which suggests some level of oversight and potential capital support if needed.

---

4. Recommendations

To improve ALETHIC LTD’s financial wellness and avoid critical failure (insolvency), the following actions are strongly advised:

• Urgent Cash Flow Management:
  Prioritize improving liquidity by securing short-term funding—either through shareholder loans, external financing, or advance payments from clients. A healthy cash flow is the lifeblood to survive the early growth phase.

• Cost Control and Budgeting:
  Rigorously monitor and control operating expenses to reduce the burn rate. Small companies must avoid unnecessary costs to preserve their limited financial "energy."

• Seek Capital Injection:
  Consider raising additional equity or convertible debt from existing shareholders or new investors to strengthen the balance sheet and reduce negative net assets.

• Revenue Generation Focus:
  Accelerate efforts to convert software development into revenue-generating contracts or products. Delays in monetization exacerbate financial stress.

• Regular Financial Monitoring:
  Implement monthly financial reviews of vital signs (cash position, payables, receivables) to detect early warning symptoms and adjust plans swiftly.

• Professional Advice:
  Engage with financial advisors or accountants experienced with startups and micro entities to guide restructuring, cash management, and compliance.

---

Medical Analogy Summary

ALETHIC LTD is currently in a critical "financial dehydration" state, with severely low liquidity and negative equity akin to a patient in urgent need of rehydration and nutrient replenishment. Without timely intervention—capital infusion and strict financial management—the company risks entering insolvency, comparable to a worsening medical condition. However, with proper treatment and monitoring, recovery and healthy growth remain achievable.

---